BACKGROUND: Rectal cancer is a common cancer. Curative treatment frequently includes surgery, radiation, and chemotherapy, all of which can result in long-term adverse effects. OBJECTIVES: This descriptive, hypothesis-generating study sought to obtain input from survivors of rectal cancer regarding key features of their long-term experience. METHODS: The authors administered a 12-question, Internet-based survey to self-identified rectal cancer survivors to assess (a) how neuropathy, fatigue, trouble with ostomy or bowel movements, and trouble with sexual function affect daily life and (b) whether knowing about these symptoms a priori would have changed their treatment decisions. Responses are presented descriptively. Qualitative analysis assessed themes reported in response to an open-ended question. FINDINGS: Responses from 116 survivors of rectal cancer, 55 of whom provided open-ended responses, were obtained. Respondents were predominantly young and several years from treatment. They reported that their lives were affected "a lot" by bowel or ostomy trouble, trouble with sexual function, fatigue, and nerve toxicity. Survivors reported that knowing whether symptoms would affect their lives "a lot" would have changed their treatment decisions with a priori knowledge of these lasting effects. Key qualitative themes were the lack of information about and support for negative effects.
BACKGROUND:Rectal cancer is a common cancer. Curative treatment frequently includes surgery, radiation, and chemotherapy, all of which can result in long-term adverse effects. OBJECTIVES: This descriptive, hypothesis-generating study sought to obtain input from survivors of rectal cancer regarding key features of their long-term experience. METHODS: The authors administered a 12-question, Internet-based survey to self-identified rectal cancer survivors to assess (a) how neuropathy, fatigue, trouble with ostomy or bowel movements, and trouble with sexual function affect daily life and (b) whether knowing about these symptoms a priori would have changed their treatment decisions. Responses are presented descriptively. Qualitative analysis assessed themes reported in response to an open-ended question. FINDINGS: Responses from 116 survivors of rectal cancer, 55 of whom provided open-ended responses, were obtained. Respondents were predominantly young and several years from treatment. They reported that their lives were affected "a lot" by bowel or ostomy trouble, trouble with sexual function, fatigue, and nerve toxicity. Survivors reported that knowing whether symptoms would affect their lives "a lot" would have changed their treatment decisions with a priori knowledge of these lasting effects. Key qualitative themes were the lack of information about and support for negative effects.
Entities:
Keywords:
cancer survivor; informational needs; rectal cancer; symptom burden
Authors: Olga Husson; Melissa S Y Thong; Floortje Mols; Simone Oerlemans; Adrian A Kaptein; Lonneke V van de Poll-Franse Journal: Psychooncology Date: 2012-02-06 Impact factor: 3.894
Authors: John Z Ayanian; Alan M Zaslavsky; Edward Guadagnoli; Charles S Fuchs; Kathleen J Yost; Cynthia M Creech; Rosemary D Cress; Lilia C O'Connor; Dee W West; William E Wright Journal: J Clin Oncol Date: 2005-08-22 Impact factor: 44.544
Authors: Brenda K Edwards; Elizabeth Ward; Betsy A Kohler; Christie Eheman; Ann G Zauber; Robert N Anderson; Ahmedin Jemal; Maria J Schymura; Iris Lansdorp-Vogelaar; Laura C Seeff; Marjolein van Ballegooijen; S Luuk Goede; Lynn A G Ries Journal: Cancer Date: 2010-02-01 Impact factor: 6.860
Authors: Jane C Weeks; Paul J Catalano; Angel Cronin; Matthew D Finkelman; Jennifer W Mack; Nancy L Keating; Deborah Schrag Journal: N Engl J Med Date: 2012-10-25 Impact factor: 91.245
Authors: Melissa S Y Thong; Floortje Mols; Xin S Wang; Valery E P P Lemmens; Tineke J Smilde; Lonneke V van de Poll-Franse Journal: Eur J Cancer Date: 2013-03-01 Impact factor: 9.162
Authors: Amy L Sapp; Amy Trentham-Dietz; Polly A Newcomb; John M Hampton; Carol M Moinpour; Patrick L Remington Journal: Cancer Date: 2003-10-15 Impact factor: 6.860
Authors: Robert S Krouse; Lisa J Herrinton; Marcia Grant; Christopher S Wendel; Sylvan B Green; M Jane Mohler; Carol M Baldwin; Carmit K McMullen; Susan M Rawl; Eric Matayoshi; Stephen Joel Coons; Mark C Hornbrook Journal: J Clin Oncol Date: 2009-08-31 Impact factor: 44.544
Authors: Virginia Sun; Christopher S Wendel; Wendy Demark-Wahnefried; Marcia Grant; Carmit K McMullen; Joanna E Bulkley; Lisa J Herrinton; Mark C Hornbrook; Robert S Krouse Journal: Nutr Cancer Date: 2018-12-20 Impact factor: 2.900
Authors: Alexander R Moschen; Yossi Sammy; Zoe Marjenberg; Amy B Heptinstall; Nick Pooley; Agnieszka M Marczewska Journal: Curr Oncol Rep Date: 2022-03-24 Impact factor: 5.945